{"nct_id":"NCT06034002","title":"A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms","status":"RECRUITING","status_verified_date":"2025-05","start_date":"2023-12-04","start_date_type":"ACTUAL","primary_completion_date":"2028-10-29","primary_completion_date_type":"ESTIMATED","completion_date":"2028-10-29","completion_date_type":"ESTIMATED","phases":["PHASE1"],"tickers":["INCY"]}